Success Metrics

Clinical Success Rate
95.2%

Based on 100 completed trials

Completion Rate
95%(100/105)
Active Trials
1(1%)
Results Posted
11%(11 trials)
Terminated
5(5%)

Phase Distribution

Ph early_phase_1
1
1%
Ph phase_2
21
19%
Ph phase_3
23
21%
Ph phase_4
21
19%
Ph not_applicable
15
14%
Ph phase_1
23
21%

Phase Distribution

24

Early Stage

21

Mid Stage

44

Late Stage

Phase Distribution104 total trials
Early Phase 1First-in-human
1(1.0%)
Phase 1Safety & dosage
23(22.1%)
Phase 2Efficacy & side effects
21(20.2%)
Phase 3Large-scale testing
23(22.1%)
Phase 4Post-market surveillance
21(20.2%)
N/ANon-phased studies
15(14.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.3%

100 of 106 finished

Non-Completion Rate

5.7%

6 ended early

Currently Active

1

trials recruiting

Total Trials

110

all time

Status Distribution
Active(1)
Completed(100)
Terminated(6)
Other(3)

Detailed Status

Completed100
Terminated5
unknown3
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
110
Active
1
Success Rate
95.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.0%)
Phase 123 (22.1%)
Phase 221 (20.2%)
Phase 323 (22.1%)
Phase 421 (20.2%)
N/A15 (14.4%)

Trials by Status

withdrawn11%
completed10091%
unknown33%
terminated55%
active_not_recruiting11%

Recent Activity

Clinical Trials (110)

Showing 20 of 110 trialsScroll for more
NCT02369406Phase 2

Early Infant HIV Treatment in Botswana

Active Not Recruiting
NCT00042289

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Completed
NCT03194165

Population Pharmacokinetics of Antiretroviral in Children

Completed
NCT00144261Phase 4

An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects

Completed
NCT00144248Phase 4

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

Completed
NCT01789879Phase 2

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy

Completed
NCT00074412Phase 3

Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding

Completed
NCT02712801Phase 4

Antiretroviral Regime for Viral Eradication in Newborns

Completed
NCT03088410Phase 4

Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana

Completed
NCT00260078Phase 1

Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children

Completed
NCT00672412Phase 1

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand

Completed
NCT00109590Phase 2

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Completed
NCT00074581Phase 3

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Completed
NCT00001095Phase 2

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Completed
NCT00000770Phase 2

A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine

Completed
NCT00000872Phase 2

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Completed
NCT00006396Phase 3

Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns

Completed
NCT00000808Phase 1

A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers

Completed
NCT00001091Phase 1

Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens

Completed
NCT00001083Phase 2

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Completed

Drug Details

Intervention Type
DRUG
Total Trials
110